Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19.

Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19.
复制标题

DOI:
10.1136/jclinpath-2021-207768
复制
发表时间:
2021-09-13
影响因子:
3.4
通讯作者:
Swiss Digital Pathology Consortium (SDiPath)
Swiss Digital Pathology Consortium (SDiPath)
中科院分区:
医学3区
文献类型:
--
作者:
Koelzer VH;Grobholz R;Zlobec I;Janowczyk A;Swiss Digital Pathology Consortium (SDiPath)

文献摘要

参考文献

被引文献

相似文献

瑞士从模拟病理学向数字病理学(DP)的转变恰逢2019冠状病毒病危机。瑞士数字病理学联合会进行了一项全国调查,以评估病理学家在应对大流行挑战方面的经验,以及这如何影响DP的前景和采用。针对在私人诊所、社区和大学医院处于不同经验阶段的瑞士病理学家进行了一项调查,其中包含20个问题,涉及大流行期间的DP、个人经历和挑战。74名受访者均为病理学家,其中81.1%报告有5年以上的诊断服务经验。32.5%的人报告在诊断环境中阅读了100张或更多的数字幻灯片。39.2%的人报告在他们的主要工作场所使用整个幻灯片成像系统。在COVID-19封锁之前,DP的主要用例是肿瘤委员会(39.2%)、教育(60.8%)和研究(44.6%),其中用于初步诊断的DP占13.5%。在2019冠状病毒病危机期间,DP用于初级诊断的使用率增加了一倍多(30%对13.5%),其中内部咨询是重要的驱动因素(22.5%对16.5%),而研究使用(25%对44.6%)和外部咨询(17.5%对41.9%)则大幅下降。确定的主要挑战包括缺乏既定的标准操作程序和专业硬件和软件的可用性。这项调查表明,危机在促进基本工作流程已经建立的中心采用发展计划方面发挥了催化剂的作用,同时对处于发展计划实施早期阶段的机构提出了重大的技术和组织挑战。
The transition from analogue to digital pathology (DP) in Switzerland has coincided with the COVID-19 crisis. The Swiss Digital Pathology Consortium conducted a national survey to assess the experience of pathologists in dealing with the challenges of the pandemic and how this has influenced the outlook and adoption of DP. A survey containing 20 questions relating to DP, personal experiences and challenges during the pandemic was addressed to Swiss pathologists at different experience stages in private practice, community and university hospitals. All 74 respondents were pathologists, with 81.1% reporting more than 5 years of diagnostic service experience. 32.5% reported having read 100 digital slides or more in a diagnostic context. 39.2% reported using whole slide imaging systems at their primary workplace. Key DP use cases before the COVID-19 lockdown were tumour boards (39.2%), education (60.8%) and research (44.6%), with DP used for primary diagnosis in 13.5%. During the COVID-19 crisis, the use of DP for primary diagnostics more than doubled (30% vs 13.5%), with internal consults as important drivers (22.5% vs 16.5%), while research use (25% vs 44.6%) and external consults (17.5% vs 41.9%) strongly decreased. Key challenges identified included a lack of established standard operating procedures and availability of specialised hardware and software. This survey indicates that the crisis acted as a catalyst in promoting DP adoption in centres where basic workflows were already established while posing major technical and organisational challenges in institutions that were at an early stage of DP implementation.
DOI: 10.1016/s1470-2045(20)30391-0
发表时间: 2020-08
期刊: The Lancet. Oncology
影响因子: --
作者:
Hamilton W
通讯作者: Hamilton W
DOI: 10.1136/jclinpath-2020-206943
发表时间: 2020-11-01
影响因子: 3.4
作者:
Cimadamore, Alessia;Lopez-Beltran, Antonio;Montironi, Rodolfo
通讯作者: Montironi, Rodolfo
DOI: 10.1136/jclinpath-2020-206786
发表时间: 2021-03
影响因子: 3.4
作者:
Browning L;Fryer E;Roskell D;White K;Colling R;Rittscher J;Verrill C
通讯作者: Verrill C
DOI: 10.1016/j.anndiagpath.2020.151612
发表时间: 2020-12-01
影响因子: 2
作者:
Samueli, Benzion;Sror, Neta;Taragin, Benjamin
通讯作者: Taragin, Benjamin
DOI: 10.1016/j.imu.2020.100432
发表时间: 2020-01-01
影响因子: --
作者:
Alkhowailed, Mohammad S;Rasheed, Zafar;Al Abdulmonem, Waleed
通讯作者: Al Abdulmonem, Waleed